Flutamide-induced hepatotoxicity during treatment of acne - A case report

3Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Flutamide is a non-steroidal anti-androgenic drug used in the treatment of prostate cancer, acne and hirsutism. Some cases of severe flutamide-induced hepatotoxicity have been reported in the literature. We report the case of a 21-year-old female who presented with a significant increase of aminotransferase levels during the treatment of acne with flutamide, which resolved completely after discontinuation of the drug. We discuss the diagnosis, the risk/benefit ratio, and conclude that monitoring liver function tests is mandatory and that the drug should be discontinued if an increase in aminotransferase levels occurs, due to the possibility of severe liver dysfunction. © 2005 by Anais Brasileiros de Dermatologia.

Cite

CITATION STYLE

APA

Duques De Amorim, M. D. F., Duques De Amorim, P., Dias De Amorim, W. P., Ramalho De Vasconcelos, J., & Duques, P. (2005). Flutamide-induced hepatotoxicity during treatment of acne - A case report. Anais Brasileiros de Dermatologia, 80(4), 381–384. https://doi.org/10.1590/s0365-05962005000400009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free